Epocrates Newsletter

    October 2005 - Issue No. 52

This Month's Features

Where Do You CME? — September's Winning Photo

From the Epocrates Medical Editors — Addressing Dangerous Abbreviations

Breast Cancer Awareness — Free Tumor Staging Reference

Quick Poll — Are health awareness months valuable?

Epocrates in the News

Question of the Month —
What is "Bluetooth"?

Advocate of the Month —
Rita Hays, APRN, AOCNP

This Month in Medical History

Advocate of the Month

Rita Hays, APRN, AOCNP, Heartland Hematology & Oncology, Kearney, NE

Advocate of the Month

I first began using Epocrates software when I was a chemo nurse going to graduate school to become an oncology nurse practitioner. I happened to read about the program in a news magazine and downloaded the free version out of curiosity. I have been a "true believer" ever since!

When I first began using Epocrates references, it was to look up unfamiliar oncology drugs. As I have gained more experience, I have discovered many more Epocrates features that are beneficial in oncology. For example:

  • Cancer patients frequently have coexisting conditions — the Epocrates Dx disease reference allows me to quickly access concise information on a wide variety of diseases and medical conditions that may impact treatment decisions, and the MultiCheck function has helped me identify and avoid drug interactions with just a few taps on my PDA.
  • Many cancer patients receive chemotherapy doses based on their Body Surface Area (BSA), and I can quickly calculate BSA using the MedMath section.
  • Chemotherapy can decrease white blood cells (WBCs), which increase a patient’s risk of infection — the Epocrates ID treatment guide provides a step-by-step approach to choosing the right antibiotic and the correct dose.
  • MobileCME helps me stay informed of new developments in oncology.
  • I can use Epocrates to teach my patients about their chemo regimens and potential drug side effects.
  • The notes section is a great place for me to track chemo drugs and their emetic potential, and remind myself of combination therapies with frequently used drugs such as antiemetics.

Epocrates helps me provide the best care I can for my patients. I believe that Epocrates is an invaluable resource and I recommend it to my colleagues for its convenience, conciseness, and accuracy. I like that I can trust it will be up to date with the AutoUpdate feature. Over the years, I have also found it to be easily downloaded and installed on each PDA that I have owned.

I am empowering the next generation of nurses as well. I purchased the Epocrates Essentials reference for my twin daughters who are now in BSN programs at the University of Nebraska Medical Center. They report to me regularly how helpful it is to them, and even better, how cool I am to have bought them Epocrates!

This Month in
Medical History

1805 — The first pharmacopoeia prepared by a US medical society was authorized by the members of the Massachusetts Medical Society. It was published in 1808, included in Thomas Jefferson's library (which he sold to the Library of Congress in 1815), and formed the core of the first National US Pharmacopoeia, published in 1820.

hurricane aid Hurricane Aid

Where Do You CME? Photo Contest
September's Winning Photo

MCME photo contest winnerCongratulations to
Dr. Carl Tommaso — his Where do you CME? entry combines the traditional cowboy with the modern physician, and was our September Photo of the Month!

Dr. Tommaso earned CME credits while waiting at the rope for a rodeo. As well as winning the rodeo, Dr. Tommaso wins a $100 American Express gift card and is a finalist for the $3,000 grand prize.

We received many great entries showing that MobileCME users really are earning CME everywhere. Other Epocrates employee favorites included customers fishing, walking on a treadmill, and waiting for a haircut! We are awarding these runners-up a free 6-month Epocrates Essentials subscription.

From the Epocrates Medical Editors

Addressing Dangerous Abbreviations

In an effort to reduce medication errors, the Joint Commission (JCAHO) and the Institute for Safe Medication Practices (ISMP) have published lists of commonly used abbreviations, symbols, and acronyms that should be avoided when prescribing medications, due to the danger of misinterpretation. Although the information in Epocrates references is in a typed rather than handwritten format, our editors have been investigating ways that our applications could be modified to support this important safety endeavor. 

We are in the process of evaluating the existence of some of these abbreviations in the Epocrates Rx drug database and are attempting to eliminate them where feasible. However, the use of abbreviations is inherent to the very concise format of Epocrates Rx. Spelling out many of the abbreviations in question would drastically change the look and presentation of the content and could potentially lead to increased confusion when viewing the dosing recommendations on a small handheld screen. In addition, changes of this nature would require a complete recoding of certain sections. Because of this complexity, we are carefully researching our options and potential solutions. This research involves meetings and correspondence with representatives at ISMP, as well as surveys to our users.

Our goal is to arrive at a resolution that will benefit prescribers and their patients, and still allow us to provide the accurate, concise, and quickly accessed drug information that our customers have come to depend upon. The first abbreviations that have been targeted in the Epocrates Rx drug database are “U” and “IU", which have been replaced with “unit” and “units” respectively.

We will keep you updated on other changes to our content as we continue to investigate how we can support JCAHO and ISMP in their campaign to promote safe prescribing habits.

Clinical Updates

In September, we added 35 new drugs, including 1 new vaccine and 24 ophthalmic products, to our content and made 154 edits to existing monographs.

Drug Edit Highlights:

  • cetuximab (Erbitux) – Updated dosing information and adverse reactions to reflect MedWatch Safety labeling changes on monitoring recommendations and an increased incidence of hypomagnesemia observed in clinical trials
  • lamotrigine (Lamictal) – Updated dosing information, contraindications/cautions, and serious reactions to reflect recent product labeling changes on clinical worsening and suicidality in patients with bipolar disorder
  • trastuzumab (Herceptin) – Updated dosing information to include monitoring of cardiac function based on recent MedWatch Safety labeling changes on updated cardiotoxicity information
  • Brands Discontinued in US: Ancef, Decadron, Humibid DM, Humibid L.A., Ocupress, Proventil Repetabs, Stadol NS, Tolectin, Tolectin DS, Ventolin inhaled, Xylocaine

Breast Cancer Awareness ribbonBreast Cancer Awareness

October is National Breast Cancer Awareness Month (NBCAM), a collaboration of more than a dozen professional medical associations, charities, and government agencies, including the ACS, ACOG, ASCO, CDC, NCI, and NMA.

The National Breast Cancer Awareness campaign continues to stress the importance of early detection through annual mammography screening for women over 40. As part of this month-long event, October 21 will be highlighted as National Mammography Day.

The NBCAM Board of Sponsors offers a wealth of resources for healthcare professionals (PDF).

Free NCI Tumor Staging Reference

We would like to remind you that a free National Cancer Institute Tumor Staging Reference is available for customers with Palm OS® mobile devices.

The NCI Tumor Staging Reference MedTools application enables you to quickly and easily access tumor staging information for a particular cancer, either alphabetically or by body location/system.

Quick Poll — Give Us Your Opinion

Do you think that health awareness events such as National Breast Cancer Awareness Month are valuable?

Please note that poll questions can only be answered via the HTML version of our newsletter email.

To find out how your colleagues answered, be sure to read the November newsletter from Epocrates!

Last month we asked: The CDC recommends that all adults receive the Tetanus-Diphtheria vaccine every 10 years. Are your patients aware of that recommendation? 62% said yes. 38% said no.

Epocrates in the News

Health Management Technology“MobileCME gives physicians the option to complete CME courses on PDAs, Smartphones and other hand-held devices.”

American Medical News“The effort to bring continuing medical educations into physicians’ practices is taking hold [with MobileCME]. ”

Health Data Management“Oswego County OB/GYN physicians also use PDAs to check drug reference information on Epocrates.”

Question of the Month

Q. What is "Bluetooth"?

A. Bluetooth is a technology that enables mobile phones, computers, personal digital assistants (PDAs), and other accessories (e.g., computer mouse, phone headset) to be interconnected wirelessly. Devices that are "bluetooth-enabled" automatically recognize each other and can exchange information and files at short range. A major advantage of Bluetooth is its ability to replace messy cables in an office, ambulance, or operating theater. In a blue-tooth-enabled medical setting, healthcare professionals can access and synchronize patient data from a variety of sources with their PDA. Many PDAs have Bluetooth and "Wi-Fi" technologies, which can perform different tasks simultaneously. If you have the choice, Bluetooth is slower and more localized than "Wi-Fi", but it uses less power.

Believe it or not, Bluetooth was named after a 10th century Danish king, Harald Bluetooth, who is credited with uniting Denmark and many of the Scandinavian Isles. Today's Bluetooth technology unifies devices rather than countries!

Epocrates, Inc., 1100 Park Place Suite 300, San Mateo, CA 94403 | www.epocrates.com

Home   Products   Services   Support   Company